Vera Therapeutics Inc (VERA)
US$ 23.22-1.07%
Price Chart
Key Statistics
Market Cap
$ 1.35B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
895.07K
52W High
$ 51.61
52W Low
$ 18.53
Dividend Yield
0.00%
Beta
1.28
Technicals
50-Day MA
24.2802
200-Day MA
36.0053
52 Week High
51.61
52 Week Low
18.53
About VERA
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with serious immunological diseases.
Employees
152
Headquarters
Brisbane, CA
CEO
Dr. Marshall W. Fordyce M.D.
Latest News
Quality-of-Life Improvement Is Highly Valued in Polycythemia Vera - Targeted Oncology
Yesterday • Google News
Vera Therapeutics: Huge Catalyst Upcoming For Kidney Disease Drug (NASDAQ:VERA) - Seeking Alpha
3 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg